title: Free HIV antiretroviral therapy enhances adherence among individuals on stable treatment: implications for potential shortfalls in free antiretroviral therapy.
abstract: OBJECTIVE
  To estimate the population-level causal effect of source of payment for HIV medication on treatment adherence using Marginal Structural Models.
  
  
  METHODS
  Data were obtained from an observational cohort of 76 HIV-infected individuals with at least 24 weeks of antiretroviral therapy treatment from 2002 to 2007 in Kampala, Uganda. Adherence was the primary outcome and it was measured using the 30-day visual analogue scale. Marginal structural models (MSM) were used to estimate the effect of source of payment for HIV medication on adherence, adjusting for confounding by income, duration on antiretroviral therapy (ART), timing of visit, prior adherence, prior CD4⁺ T cell count and prior plasma HIV RNA. Traditional association models were also examined and the results compared.
  
  
  RESULTS
  Free HIV treatment was associated with a 3.8% improvement in adherence in the marginal structural model, while the traditional statistical models showed a 3.1-3.3% improvement in adherence associated with free HIV treatment.
  
  
  CONCLUSIONS
  Removing a financial barrier to treatment with ART by providing free HIV treatment appears to significantly improve adherence to antiretroviral therapy. With sufficient information on confounders, MSMs can be used to make robust inferences about causal effects in epidemiologic research.
authors.affiliation: Department of Epidemiology and Biostatistics, School of Public Health, Makerere University College of Health Sciences, Kampala, Uganda.
authors.forename: Jayne
authors.initials: J
authors.lastname: Byakika-Tusiime
authors.forename: Eric C
authors.initials: EC
authors.lastname: Polley
authors.forename: Jessica H
authors.initials: JH
authors.lastname: Oyugi
authors.forename: David R
authors.initials: DR
authors.lastname: Bangsberg
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000191:economics / Q000627:therapeutic use*; D015331:Cohort Studies; D016527:Drug Costs; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D017048:Health Care Costs; D006801:Humans; D008297:Male; D055118:Medication Adherence; D015999:Multivariate Analysis
chemical_list: D019380:Anti-HIV Agents
references.citation: Int J STD AIDS. 2005 Jan;16(1):38-41
references.pmid: 15705271
references.citation: J Acquir Immune Defic Syndr. 2006 Dec 1;43 Suppl 1:S119-22
references.pmid: 17133194
references.citation: AIDS Res Hum Retroviruses. 2004 Oct;20(10):1053-6
references.pmid: 15585095
references.citation: HIV Clin Trials. 2004 Mar-Apr;5(2):74-9
references.pmid: 15116282
references.citation: AIDS Behav. 2010 Aug;14(4):778-84
references.pmid: 19283464
references.citation: Appl Health Econ Health Policy. 2006;5(3):137-53
references.pmid: 17132029
references.citation: Am J Epidemiol. 2004 May 15;159(10):926-34
references.pmid: 15128604
references.citation: AIDS. 2007 May 11;21(8):965-71
references.pmid: 17457090
references.citation: AIDS. 2008 Jul;22 Suppl 1:S161-8
references.pmid: 18664948
references.citation: AIDS. 2003 Jul;17 Suppl 3:S103-8
references.pmid: 14565616
references.citation: Epidemiology. 2000 Sep;11(5):550-60
references.pmid: 10955408
references.citation: Int J Biostat. 2010;6(2):Article 2
references.pmid: 21969992
references.citation: PLoS Med. 2006 Nov;3(11):e438
references.pmid: 17121449
references.citation: AIDS Behav. 2006 Jul;10(4):437-42
references.pmid: 16636892
references.citation: Bull World Health Organ. 2009 Apr;87(4):279-87
references.pmid: 19551236
references.citation: J Acquir Immune Defic Syndr. 2006 Dec 1;43 Suppl 1:S96-S103
references.pmid: 17133209
references.citation: Trop Med Int Health. 2005 May;10(5):464-70
references.pmid: 15860093
references.citation: J Acquir Immune Defic Syndr. 2004 Aug 15;36(5):1100-2
references.pmid: 15247564
references.citation: Health Policy Plan. 1996 Mar;11(1):52-63
references.pmid: 10155878
references.citation: AIDS. 2002 Jan 25;16(2):269-77
references.pmid: 11807312
references.citation: J Acquir Immune Defic Syndr. 2003 Nov 1;34(3):281-8
references.pmid: 14600572
references.citation: Am J Epidemiol. 2005 Aug 15;162(4):382-8
references.pmid: 16014771
references.citation: Clin Infect Dis. 2007 Oct 1;45(7):908-15
references.pmid: 17806060
references.citation: Am J Epidemiol. 2003 Oct 1;158(7):687-94
references.pmid: 14507605
references.citation: Epidemiology. 2000 Sep;11(5):561-70
references.pmid: 10955409